JP2023542701A5 - - Google Patents
Info
- Publication number
- JP2023542701A5 JP2023542701A5 JP2023519000A JP2023519000A JP2023542701A5 JP 2023542701 A5 JP2023542701 A5 JP 2023542701A5 JP 2023519000 A JP2023519000 A JP 2023519000A JP 2023519000 A JP2023519000 A JP 2023519000A JP 2023542701 A5 JP2023542701 A5 JP 2023542701A5
- Authority
- JP
- Japan
- Prior art keywords
- mitapibat
- approximately
- amount
- composition according
- child
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063083834P | 2020-09-25 | 2020-09-25 | |
| US63/083,834 | 2020-09-25 | ||
| US202063107196P | 2020-10-29 | 2020-10-29 | |
| US63/107,196 | 2020-10-29 | ||
| US202163238483P | 2021-08-30 | 2021-08-30 | |
| US63/238,483 | 2021-08-30 | ||
| PCT/US2021/051957 WO2022067039A1 (en) | 2020-09-25 | 2021-09-24 | Pharmaceutical formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542701A JP2023542701A (ja) | 2023-10-11 |
| JP2023542701A5 true JP2023542701A5 (enExample) | 2024-10-01 |
Family
ID=78179552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519000A Pending JP2023542701A (ja) | 2020-09-25 | 2021-09-24 | 薬学的製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230338283A1 (enExample) |
| EP (1) | EP4216956A1 (enExample) |
| JP (1) | JP2023542701A (enExample) |
| KR (1) | KR20230074536A (enExample) |
| AU (1) | AU2021347349A1 (enExample) |
| CA (1) | CA3196829A1 (enExample) |
| IL (1) | IL301596A (enExample) |
| MX (1) | MX2023003431A (enExample) |
| TW (1) | TW202228691A (enExample) |
| WO (1) | WO2022067039A1 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201403696UA (en) | 2009-06-29 | 2014-10-30 | Agios Pharmaceuticals Inc | Therapeutic compounds and compositions |
| RS64777B1 (sr) | 2015-06-11 | 2023-11-30 | Agios Pharmaceuticals Inc | Postupci upotrebe aktivatora piruvat kinaze |
| US11254652B2 (en) | 2017-11-22 | 2022-02-22 | Agios Pharmaceuticals, Inc. | Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide |
-
2021
- 2021-09-24 EP EP21791565.1A patent/EP4216956A1/en active Pending
- 2021-09-24 MX MX2023003431A patent/MX2023003431A/es unknown
- 2021-09-24 US US18/028,058 patent/US20230338283A1/en active Pending
- 2021-09-24 AU AU2021347349A patent/AU2021347349A1/en active Pending
- 2021-09-24 JP JP2023519000A patent/JP2023542701A/ja active Pending
- 2021-09-24 WO PCT/US2021/051957 patent/WO2022067039A1/en not_active Ceased
- 2021-09-24 CA CA3196829A patent/CA3196829A1/en active Pending
- 2021-09-24 KR KR1020237013787A patent/KR20230074536A/ko active Pending
- 2021-09-24 IL IL301596A patent/IL301596A/en unknown
- 2021-09-24 TW TW110135559A patent/TW202228691A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI335217B (en) | Pharmaceutical formulations of modafinil | |
| JP6491174B2 (ja) | ニタゾキサニドの制御放出医薬配合物 | |
| KR20140121491A (ko) | 체중 감량을 성취하고 비만을 치료하기 위한 단계적상승 투여 요법 | |
| US20110081385A1 (en) | Compositions and Methods for Sleep Regulation | |
| WO2003092682A1 (en) | Zonisamide use in obesity and eating disorders | |
| JPH0635382B2 (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| KR20230008913A (ko) | 알펠리십을 포함하는 제약 조성물 | |
| JP2022525202A (ja) | 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と１日あたりの投薬量 | |
| BG65637B1 (bg) | Използване на мелатонин във форма с контролирано освождаване за лечение на резистентност към антихипертензивни препарати и подобни състояния | |
| JP2004525940A (ja) | 火照りの処置のためのデュロキセチン | |
| NO20001717L (no) | Serotonin-inneholdende formulering for oral administrering og anvendelse av samme | |
| EP1496868A1 (en) | Controlled release pharmaceutical compositions of carbidopa and levodopa | |
| US20240100011A1 (en) | Pediatric formulations of ferric citrate | |
| CN101175477A (zh) | 碘塞罗宁的控释药物组合物及其制备和使用方法 | |
| JP7738832B2 (ja) | 低亜鉛血症治療剤 | |
| Serafini et al. | The use of rotigotine in the treatment of restless legs syndrome | |
| JP2025501922A5 (enExample) | ||
| CN107281200A (zh) | 一种含1,6‑二磷酸果糖的复方固体制剂及其制备方法 | |
| JP2004532866A (ja) | ２型インスリン抵抗性真性糖尿病患者の治療のためのビオチンと組合せてのアセチルｌ−カルニチンの使用 | |
| US20240216284A1 (en) | Alpelisib formulation | |
| KR101362679B1 (ko) | 프랄나카산의 지연 방출 제형 | |
| CN110913843A (zh) | 药物组合物 | |
| WO2024155828A1 (en) | Uses of aminopyridines in the management of weight and satiety | |
| JP2023553354A5 (enExample) |